LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris

Registry ID

EUCTR2016-000556-95

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

LEO Pharma A/S

Start date

2016-10-24

Completion date

2019-07-02

Last update

2026-08-16

Conditions

• Psoriasis vulgaris

Summary

The primary objective is to evaluate the efficacy of a twice weekly maintenance regimen with LEO 90100 compared to vehicle in the prevention of relapse in subjects with psoriasis vulgaris.

Locations

• , , Poland
• , , UK
• , , France

Related clinical trials

• Investigation of maintaining factors of depressive disorders in patients with psoriasis
• Evaluation of a structured, guideline-based, multimodal care model for people with inflammatory skin diseases
• Pharmacological conditioning as a drug dose reduction strategy in patients with psoriasis
• Characterising inflammatory and malignant skin diseases
• Pruritus and Psoriasis - experimental analyses of itch in patients with psoriasis
• Disease trajectories in Atopic Dermatitis and Psoriasis

View on source registry